申请人:MERCK SHARP & DOHME CORP.
公开号:US20140296136A1
公开(公告)日:2014-10-02
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
本发明涉及公式(I)的大环化合物,它们是丙型肝炎病毒(HCV)NS3蛋白酶的抑制剂,它们的合成以及它们用于治疗或预防HCV感染的用途。